Calvin Knowlton, BScPharm, MDiv, PhD ’93, awarded honorary Doctor of Sciences in recognition of his decades of leadership in the fields of pharmacy, business, and philanthropy.

With inquisitive nature and ability to multitask, director of pharmaceutical research computing is a great asset to the School of Pharmacy.

Director of research for PATIENTS Program honored for work in patient-centered outcomes research and role as principal investigator for project with Southwest Partnership.

Anthony Wutoh, provost and chief academic officer at Howard University, says we must work together for our collective future and the good of society.

Research led by Dr. Zafar Zafari will help inform future studies and guide policy decisions to reduce health care and economic costs associated with COPD in the U.S.

Key stakeholders from The PATIENTS Program come together to celebrate past achievements and look towards future successes.

The Robert Wood Johnson Foundation’s Culture of Health Leaders program will provide Dr. Danya Qato with the tools to support her development as an agent of change for health equity and structural transformation.

Award from the Maryland Industrial Partnerships (MIPS) program supports work to formulate Clofazimine for treatment of recurrent C. difficile infections.

Inaugural event helps amplify the community’s voice and demonstrates the value of early engagement in research.

New center established by the School of Pharmacy, in collaboration with the University of Michigan, will increase access to safe and effective generic drugs through collaborative research, training, and exchange.

Meeting brings together 360 stakeholders from across academia, government, and industry to explore methods to develop better models that can identify and accurately predict drug risks and efficacy.

Information about the molecular shape of the viruses that cause COVID-19, SARS, and MERS reveals structural similarities that suggest possible drug treatments.